Phychem Technologies Limited (BOM:544902)
49.37
-2.59 (-4.98%)
At close: Sep 11, 2026
Phychem Technologies Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 564.65 | 503.03 | 469.69 | 422.71 | 315.03 |
Other Revenue | 1.45 | 1.82 | 1.43 | 0.93 | - |
| 566.11 | 504.85 | 471.13 | 423.63 | 315.03 | |
Revenue Growth | 12.13% | 7.16% | 11.21% | 34.47% | 22.96% |
Cost of Revenue | 433.35 | 393.05 | 382.77 | 349.93 | 270.98 |
Gross Profit | 132.76 | 111.8 | 88.36 | 73.7 | 44.06 |
Selling, General & Admin | 11.45 | 12.41 | 10.22 | 7.57 | 4.21 |
Other Operating Expenses | 54.75 | 50.13 | 42.89 | 41.27 | 25.8 |
Operating Expenses | 71.43 | 67.53 | 59.3 | 52.12 | 32.86 |
Operating Income | 61.33 | 44.27 | 29.06 | 21.59 | 11.19 |
Interest Expense | -10.35 | -8.65 | -6.1 | -6.02 | -4.47 |
Interest & Investment Income | 0.72 | 0.55 | 0.33 | 0.14 | 0.13 |
Currency Exchange Gain (Loss) | 3.68 | 1.3 | 0.39 | 2.66 | 0.64 |
Other Non Operating Income (Expenses) | 0.07 | 0.34 | -0.05 | -0.06 | 3.83 |
EBT Excluding Unusual Items | 55.45 | 37.81 | 23.63 | 18.31 | 11.33 |
Other Unusual Items | - | -7.75 | - | - | - |
Pretax Income | 55.45 | 38.16 | 23.63 | 18.31 | 11.33 |
Income Tax Expense | 14.56 | 9.74 | 6.7 | 5.16 | 2 |
Net Income | 40.89 | 28.42 | 16.94 | 13.16 | 9.33 |
Net Income to Common | 40.89 | 28.42 | 16.94 | 13.16 | 9.33 |
Net Income Growth | 43.89% | 67.76% | 28.73% | 41.00% | 33.85% |
Shares Outstanding (Basic) | 8 | 8 | 8 | 8 | 8 |
Shares Outstanding (Diluted) | 8 | 8 | 8 | 8 | 8 |
Shares Change | - | - | - | 0.00% | -0.01% |
EPS (Basic) | 5.42 | 3.77 | 2.25 | 1.75 | 1.24 |
EPS (Diluted) | 5.42 | 3.77 | 2.25 | 1.75 | 1.24 |
EPS Growth | 43.81% | 67.76% | 28.73% | 40.99% | 33.86% |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 2.64 | 21.26 | 1.69 | -0.73 | 4.8 |
Free Cash Flow Per Share | 0.35 | 2.82 | 0.22 | -0.10 | 0.64 |
Gross Margin | 23.45% | 22.14% | 18.75% | 17.40% | 13.98% |
Operating Margin | 10.83% | 8.77% | 6.17% | 5.10% | 3.55% |
Profit Margin | 7.22% | 5.63% | 3.60% | 3.11% | 2.96% |
Free Cash Flow Margin | 0.47% | 4.21% | 0.36% | -0.17% | 1.52% |
EBITDA | 66.56 | 49.25 | 33.09 | 24.85 | 14.05 |
EBITDA Margin | 11.76% | 9.76% | 7.02% | 5.87% | 4.46% |
D&A For EBITDA | 5.23 | 4.98 | 4.03 | 3.26 | 2.86 |
EBIT | 61.33 | 44.27 | 29.06 | 21.59 | 11.19 |
EBIT Margin | 10.83% | 8.77% | 6.17% | 5.10% | 3.55% |
Effective Tax Rate | 26.25% | 25.52% | 28.33% | 28.15% | 17.63% |
Revenue as Reported | 574.81 | 511.13 | 475.88 | 431.87 | 328.58 |